Truncated immune system receptors may regulate cellular activity
Unexpected findings in chemokine receptors once believed to be non-functional open up new fields of scientific inquiry.
Tyler Jacks, founding director of MIT’s Koch Institute, to step down
A search committee chaired by Institute Professor Phillip Sharp will work to identify a new director for MIT’s pioneering cancer research center.
Silencing gene expression to cure complex diseases
Immuneering uses bioinformatics to develop new medicines while also helping large pharmaceutical companies improve their treatments.
To make mini-organs grow faster, give them a squeeze
Study finds that compressing cells, and crowding their contents, can coax them to grow and divide.
Cancer researchers collaborate, target DNA damage repair pathways for cancer therapy
MIT researchers find blocking the expression of the genes XPA and MK2 enhances the tumor-shrinking effects of platinum-based chemotherapies in p53-mutated cancers.
Regina Barzilay wins $1M Association for the Advancement of Artificial Intelligence Squirrel AI award
MIT professor announced as award’s first recipient for work in cancer diagnosis and drug synthesis.
Gene-controlling mechanisms play key role in cancer progression
Study finds “epigenomic” alterations evolve as lung tumors become more aggressive and metastasize.
How cancer drugs find their targets
Certain cancer therapeutics concentrate within cells — a finding that could change the way scientists think about drug design.
Counting your antigens
A new platform that precisely quantifies antigens presented on cell surfaces may help researchers and clinicians improve the effectiveness of cancer immunotherapies.
A boost for cancer immunotherapy
Engineers design nanoparticles that stimulate the immune system, helping it to attack tumors.
Deep learning accurately stains digital biopsy slides
Pathologists who examined the computationally stained images could not tell them apart from traditionally stained slides.
Making an impact through chemical engineering
Hadley Sikes designs simple-to-use diagnostic devices that could benefit patients around the world.
New sensors could offer early detection of lung tumors
Study shows that a simple urine test can reveal the presence of lung cancer in mice.
Thank you for your patients
An unusual synergy between cancer researchers, clinical centers, and industry leads to promising clinical trials for a new combination therapy for prostate cancer.
An entrepreneur finds his way to MIT
Introduced to the Institute through MITx and MIT Bootcamps, Jakub Chudik is now a senior in EECS and CTO of his own startup.